Hope Therapeutics, an interventional psychiatry network wholly owned by NRx Pharmaceuticals (NRXP), announced signing of a definitive agreement ...
Ideaya Biosciences (IDYA) announced that the FDA has granted breakthrough therapy designation for darovasertib, a protein kinase C inhibitor, ...
Rebranding efforts include a new logo, overall brand presence, and corporate design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback